Go to content
UR Home

Exposure to cisplatin in the operating room during hyperthermic intrathoracic chemotherapy

URN to cite this document:
DOI to cite this document:
Markowiak, Till ; Ried, Michael ; Larisch, Christopher ; Nowak, Dennis ; Hofmann, Hans-Stefan ; Rakete, Stefan
License: Creative Commons Attribution 4.0
PDF - Published Version
Date of publication of this fulltext: 07 Jul 2021 06:38


Purpose Hyperthermic intrathoracic chemotherapy (HITOC) is an additive, intraoperative treatment for selected malignant pleural tumors. To improve local tumor control, the thoracic cavity is perfused with a cisplatin-containing solution after surgical cytoreduction. Since cisplatin is probably carcinogenic to humans, potential contamination of surfaces and pathways of exposure should be ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de

Dissertations: dissertationen@ur.de

Research data: daten@ur.de

Contact persons